BHPABHPA Inc.

About BHPA Inc. (BHPA)

BHPA Inc. (BHPA) is a Software - Application company headquartered in Bethesda, MD, United States whose shares trade over-the-counter on the Pink tier.

BHPA, D/B/A Aquiva Medical Inc. is a biotechnology company focused on commercializing innovative materials science technologies to disrupt and enhance the future of transdermal drug delivery systems (TDDS). The company's wholly-owned subsidiary, Aquiva Medical, has exclusively licensed a novel HiPNATM (Hydrogel with Inter-Penetrating Network Anchor) technology, which is a unique and attractive platform technology for various applications to deliver active ingredients and pharmaceuticals via transdermal patches on the skin and surrounding tissues, including the ability to better control release dosage and speed for a broader range of molecules, with more precision than existing, legacy TDDS technologies. Aquiva's current focus is on disrupting the $10.5B transdermal patch market for therapeutics.

Products and services

Transdermal drug delivery systems (TDDS) and related pharmaceutical and biotechnological formulations

BHPA key facts

Ticker symbol

BHPA

Market tier

Pink

Sector

Technology

Industry

Software - Application

Headquarters

Bethesda, MD, United States

Country of incorporation

US

Year of incorporation

2005

Employees

5

Estimated market cap

$7.65M (as of May 8, 2025)

Shares outstanding

3,826,281,559

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

3/31

Latest filing

Quarterly Report (Dec 31, 2024)

BHPA Inc. leadership

• Kevin Tseng — CEO
• David E. Price — Company Secretary, General Counsel

Explore more: Software - Application stocks · Technology sector · Pink stocks · OTC stocks starting with B